Definitive Contract 75D30121C10297

Award Date 5/5/21
Potential Completion Date 5/4/22
Potential Value $10M
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Boston, MA 02115, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $24,899,418.92 firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Children's Hospital Corporation, doing business as Boston Children's Hospital, a non-profit pediatric teaching hospital and research center. The contract is for a COVID-19 and Multisystem Inflammatory Syndrome in Children (MIS-C) Vaccine Effectiveness (VE) study, with a period of performance ending on September 15, 2026. The contract does not have a set-aside...
This is a $5,092,787.07 firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Children's Hospital Corporation, doing business as Boston Children's Hospital. The contract is for COVID-19 research focused on critically ill children and does not have a set-aside designation. Boston Children's Hospital is a non-profit pediatric teaching hospital and research center affiliated with Harvard Medical School. Through this contract, the hospital is...
This is a $9,730,025.00 definitive, firm-fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to The Children's Hospital Corporation, doing business as Boston Children's Hospital, a non-profit pediatric teaching hospital and research center. The contract, which does not have a set-aside designation, is for a scientific study with an ultimate completion date of February 22, 2028. Boston Children's Hospital, an institution affiliated with Harvard Medical School, has...
This is a $31,468,032.25 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Children's Hospital Corporation, doing business as Boston Children's Hospital, a non-profit pediatric teaching hospital and research center. The contract, titled "FLUMED FOR OTHER FUNCTIONS," has a firm fixed-price pricing arrangement and an ultimate completion date of January 30, 2023. The contract does not have a set-aside designation. Through this award, Boston...
This is a definitive contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to The Children's Hospital Corporation, doing business as Boston Children's Hospital, for influenza vaccine effectiveness for children in the United States. The contract has a firm fixed price of $1,939,144.49 and does not have a set-aside designation. Boston Children's Hospital is a pediatric teaching hospital and research center affiliated with Harvard Medical...
This is a definitive contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to The Children's Hospital Corporation, doing business as Boston Children's Hospital. The contract, valued at $279,764.00, is for the delivery of "Flu Near You and Novel Data Streams to Supplement Healthcare Utilization Surveillance." The contract does not have a set-aside designation. Boston Children's Hospital is a pediatric teaching hospital and research...
The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $423,882 delivery order contract to Boston Medical Center Corporation, doing business as BMC, under the Clinical Immunization Safety Assessment master indefinite-delivery/indefinite-quantity contract. The contract calls for BMC to provide Coronavirus COVID-19 clinical contributing services in Boston, Massachusetts from September 29, 2022 through September 28, 2023. The pricing structure is...
The Centers for Disease Control and Prevention (CDC) awarded a $1,133,672.00 Delivery Order contract to Childrens Hospital Medical Center, doing business as Children's Home Healthcare, a non-profit pediatric hospital and research center in Cincinnati, Ohio. This contract is part of the Clinical Immunization Safety Assessment (CISA) Base IDIQ, a multiple-award contract with a potential value of $86 million over a period of performance from September 2023 to September 2028. Under this IDIQ and...
This federal contract award is for a $518,366 delivery order under the Centers for Disease Control and Prevention's (CDC) Clinical Immunization Safety Assessment (CISA) IDIQ contract. The prime contractor is Childrens Hospital Medical Center (doing business as Children's Home Healthcare), a non-profit pediatric hospital and research center located in Cincinnati, Ohio. The contract is for pediatric COVID-19 vaccination services, with a period of performance through December 2025. No set-aside...
This federal contract award was made by the Office of the Assistant Secretary for Administration, a civilian agency, to The Children's Hospital Corporation, doing business as Boston Children's Hospital, a non-profit pediatric teaching hospital and research center. The contract, valued at $94,999.05, is for services to improve the child core set of measures used by Medicaid and the Children's Health Insurance Program (CHIP). The contract does not have a set-aside designation. Boston Children's...

The Centers for Disease Control and Prevention, an agency of the Department of Health and Human Services, awarded a $9,990,604.91 firm fixed price definitive contract to Boston Children's Hospital for MIS-C in Children. As the prime contractor, Boston Children's Hospital will deliver services to investigate Multisystem Inflammatory Syndrome in Children (MIS-C), a condition where different body parts can become inflamed, including the heart, lungs, kidneys, brain, skin, eyes, or gastrointestinal organs. The contract has a one-year period of performance from May 2021 through May 2022 in Boston, Massachusetts. No major subcontractors or set aside designations were identified. This award furthers the CDC's public health mission to monitor and respond to diseases of national and global importance.

Generated 12/29/23, 4:04 PM